Login / Signup

Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX.

Matthew A CavenderRobert A HarringtonGregg W StonePhillippe Gabriel StegC Michael GibsonChristian W HammMatthew J PriceRenato Deláscio LopesSergio LeonardiEfthymios N DeliargyrisJayne PratsKenneth W MahaffeyHarvey D WhiteDeepak L Bhattnull null
Published in: Circulation. Cardiovascular interventions (2021)
The reductions in ischemic events and overall efficacy seen with cangrelor in CHAMPION PHOENIX occurred early and during the period of time in which patients were being actively treated with cangrelor. These findings provide evidence that supports the importance of potent platelet inhibition during percutaneous coronary intervention. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01156571.
Keyphrases